Fremont, CA, June 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The MarketWatch News Department was not involved in the creation of this content. Fremont, CA, March 17, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics ...

FREMONT, Calif., Oct. 15, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced key additions to its executive ...

Alamar Biosciences (ALMR) climbed ~40% on Friday after the commercial-stage proteomics company priced its upsized initial public offering of roughly 11.3M shares to raise approximately $191M in gross ...

The aggressive growth fund investor was busy adding to some of her established stakes on Monday.

Strategic partnership expands Biognosys' services to include Alamar's NULISA assays as well as joint scientific research in biofluid-based proteomics Complementary value of Biognosys' DIA-MS unbiased ...

FREMONT, Calif., Jan. 11, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an ...

The MarketWatch News Department was not involved in the creation of this content. New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support ...